Pfizer Future Growth
Future criteria checks 1/6
Pfizer is forecast to grow earnings and revenue by 11.9% and 8% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 17.2% in 3 years.
Key information
11.9%
Earnings growth rate
11.9%
EPS growth rate
Pharmaceuticals earnings growth | 17.6% |
Revenue growth rate | 8.0% |
Future return on equity | 17.2% |
Analyst coverage | Low |
Last updated | 31 Dec 2024 |
Recent future growth updates
Recent updates
Some Confidence Is Lacking In Pfizer Limited's (NSE:PFIZER) P/E
Nov 28We Think Pfizer (NSE:PFIZER) Can Stay On Top Of Its Debt
Aug 31Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 25%
Aug 07Weak Statutory Earnings May Not Tell The Whole Story For Pfizer (NSE:PFIZER)
May 25Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07These 4 Measures Indicate That Pfizer (NSE:PFIZER) Is Using Debt Safely
Sep 23This Is The Reason Why We Think Pfizer Limited's (NSE:PFIZER) CEO Deserves A Bump Up To Their Compensation
Aug 12Are Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
Mar 10Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 27,198 | 8,175 | 5,415 | 5,890 | 1 |
3/31/2026 | 25,509 | 7,423 | 4,968 | 5,718 | 2 |
3/31/2025 | 23,399 | 6,387 | 7,558 | 7,988 | 2 |
9/30/2024 | 22,381 | 6,179 | 4,014 | 4,165 | N/A |
6/30/2024 | 22,247 | 6,085 | N/A | N/A | N/A |
3/31/2024 | 21,932 | 5,513 | 2,379 | 2,568 | N/A |
12/31/2023 | 22,192 | 5,021 | N/A | N/A | N/A |
9/30/2023 | 23,010 | 5,228 | 4,322 | 5,040 | N/A |
6/30/2023 | 23,632 | 6,849 | N/A | N/A | N/A |
3/31/2023 | 24,248 | 6,239 | 2,907 | 3,557 | N/A |
12/31/2022 | 24,041 | 6,201 | N/A | N/A | N/A |
9/30/2022 | 24,583 | 6,133 | 1,341 | 1,493 | N/A |
6/30/2022 | 24,571 | 4,452 | N/A | N/A | N/A |
3/31/2022 | 26,110 | 6,126 | 6,518 | 6,671 | N/A |
12/31/2021 | 25,961 | 5,873 | N/A | N/A | N/A |
9/30/2021 | 25,137 | 5,847 | 7,018 | 7,147 | N/A |
6/30/2021 | 24,728 | 5,731 | N/A | N/A | N/A |
3/31/2021 | 22,404 | 4,976 | 4,096 | 4,273 | N/A |
12/31/2020 | 22,058 | 5,001 | N/A | N/A | N/A |
9/30/2020 | 21,505 | 4,979 | 4,129 | 4,004 | N/A |
6/30/2020 | 21,221 | 5,208 | N/A | N/A | N/A |
3/31/2020 | 21,517 | 5,091 | 3,211 | 3,232 | N/A |
12/31/2019 | 21,853 | 5,156 | N/A | N/A | N/A |
9/30/2019 | 21,609 | 5,085 | 1,760 | 1,716 | N/A |
6/30/2019 | 21,136 | 4,500 | N/A | N/A | N/A |
3/31/2019 | 20,815 | 4,291 | 1,245 | 978 | N/A |
12/31/2018 | 20,658 | 4,241 | N/A | N/A | N/A |
9/30/2018 | 20,085 | 3,794 | N/A | N/A | N/A |
6/30/2018 | 20,599 | 3,947 | N/A | N/A | N/A |
3/31/2018 | 19,685 | 3,601 | N/A | 3,318 | N/A |
12/31/2017 | 18,866 | 3,236 | N/A | N/A | N/A |
9/30/2017 | 19,215 | 2,987 | N/A | N/A | N/A |
6/30/2017 | 18,860 | 3,139 | N/A | N/A | N/A |
3/31/2017 | 19,663 | 3,368 | N/A | 3,288 | N/A |
12/31/2016 | 20,453 | 2,737 | N/A | N/A | N/A |
9/30/2016 | 20,595 | 2,711 | N/A | N/A | N/A |
6/30/2016 | 20,350 | 2,276 | N/A | N/A | N/A |
3/31/2016 | 20,123 | 3,050 | N/A | 3,455 | N/A |
12/31/2015 | 19,649 | 1,680 | N/A | N/A | N/A |
9/30/2015 | 19,334 | 1,460 | N/A | N/A | N/A |
6/30/2015 | 19,018 | 861 | N/A | N/A | N/A |
3/31/2015 | 18,531 | 698 | N/A | 1,135 | N/A |
12/31/2014 | 16,632 | 1,137 | N/A | N/A | N/A |
9/30/2014 | 11,078 | 1,380 | N/A | N/A | N/A |
6/30/2014 | 11,118 | 2,194 | N/A | N/A | N/A |
3/31/2014 | 11,103 | 2,209 | N/A | 1,324 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PFIZER's forecast earnings growth (11.9% per year) is above the savings rate (6.7%).
Earnings vs Market: PFIZER's earnings (11.9% per year) are forecast to grow slower than the Indian market (18.1% per year).
High Growth Earnings: PFIZER's earnings are forecast to grow, but not significantly.
Revenue vs Market: PFIZER's revenue (8% per year) is forecast to grow slower than the Indian market (10.6% per year).
High Growth Revenue: PFIZER's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PFIZER's Return on Equity is forecast to be low in 3 years time (17.2%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 06:36 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pfizer Limited is covered by 14 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
null null | Anand Rathi Shares and Stock Brokers Limited |
Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |